[HTML][HTML] Adverse reactions of dimethyl sulfoxide in humans: a systematic review

BK Madsen, M Hilscher, D Zetner, J Rosenberg - F1000Research, 2018 - ncbi.nlm.nih.gov
Background: Dimethyl sulfoxide (DMSO) has been used for medical treatment and as a
pharmacological agent in humans since the 1960s. Today, DMSO is used mostly for …

Skin replacement in burn wounds

N Brusselaers, A Pirayesh, H Hoeksema… - Journal of Trauma …, 2010 - journals.lww.com
Historically, the main goal in burn management was increasing the survival of severely
burned patients by rapid debridement and early closure of burn wounds, consequently …

Graft cryopreservation does not impact overall survival after allogeneic hematopoietic cell transplantation using post-transplantation cyclophosphamide for graft …

M Hamadani, MJ Zhang, XY Tang, M Fei… - Biology of Blood and …, 2020 - Elsevier
The COVID-19 pandemic has created significant barriers to timely donor evaluation, cell
collection, and graft transport for allogeneic hematopoietic stem cell transplantation (allo …

Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution

K Maurer, HT Kim, TM Kuczmarski, HM Garrity… - Blood …, 2021 - ashpublications.org
We sought to evaluate the impact of cryopreservation of unrelated donor (URD) peripheral
blood stem cell (PBSC) grafts on engraftment, chimerism, and immune reconstitution in the …

[HTML][HTML] Hematopoietic cell transplantation with cryopreserved grafts for severe aplastic anemia

M Eapen, MJ Zhang, XY Tang, SJ Lee, MW Fei… - Biology of Blood and …, 2020 - Elsevier
With the COVID-19 pandemic and the ensuing barriers to the collection and transport of
donor cells, it is often necessary to collect and cryopreserve grafts before initiation of …

The effect of donor graft cryopreservation on allogeneic hematopoietic cell transplantation outcomes: a Center for International Blood and Marrow Transplant …

JW Hsu, N Farhadfar, H Murthy, BR Logan… - … and cellular therapy, 2021 - Elsevier
The COVID-19 pandemic has resulted in the increased use of cryopreserved grafts for
allogeneic hematopoietic cell transplantation (HCT). However, information about the effect of …

Allogeneic hematopoietic stem cell transplantation in the COVID-19 era

J Bordat, S Maury, M Leclerc - Frontiers in immunology, 2023 - frontiersin.org
Allogeneic hematopoietic stem-cell transplantation (allo-HSCT) recipients are especially
vulnerable to coronavirus disease 19 (COVID-19), because of their profound …

A toxicity study of multiple-administration human umbilical cord mesenchymal stem cells in cynomolgus monkeys

Y Wang, ZB Han, J Ma, C Zuo, J Geng… - Stem Cells and …, 2012 - liebertpub.com
Therapies based on stem cells have shown very attractive potential in many clinical studies.
However, the data about the safety of stem cells application remains insufficient. The present …

Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT …

N Worel, P Ljungman, ICM Verheggen… - Bone Marrow …, 2023 - nature.com
The COVID-19 pandemic has had a significant impact on medical practices, including the
delivery of allogeneic hematopoietic cell transplantation (HCT). In response, transplant …

Fresh vs. frozen allogeneic peripheral blood stem cell grafts: A successful timely option

AS Alotaibi, S Prem, S Chen, JH Lipton… - American Journal of …, 2021 - Wiley Online Library
Cryopreservation of grafts has been established in autologous and cord blood
transplantation, yet there is little experience regarding the effect of cryopreservation with …